NLT SPINE vision is to lead the minimally-invasive revolution in spine surgery. The Company develops and markets medical devices (implants and instruments) intended for the surgical treatment of back pain. NLT SPINE's first two products for lumbar interbody fusion are approved for marketing and are currently under limited release. 6 additional products will be released in 2014-2015, targeting most of the yearly $7.6 billion opportunity for spinal implants. All the Company's products are based on its NonLinear technology. NLT SPINE is headquartered in Israel, with offices in Boston, MA.